TAT-cyclo-CLLFVY TFA

SKU: orb1981514

Description

This cyclic peptide inhibitor disrupts the HIF-1α/HIF-1β heterodimerization with an IC50 of 1.3 µM, effectively blocking hypoxia signaling. It is a valuable research tool for studying hypoxia-driven pathways in cancer biology, applicable in both in vitro and in vivo experimental models.

Research Area

Epigenetics & Chromatin, Metabolism Research

Images & Validation

−

Key Properties

−

Target	HIF/HIF Prolyl-Hydroxylase
Molecular Weight	2673.1

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

HIF/HIF Prolyl-Hydroxylase

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols